Bridget Ross Net Worth

The estimated Net Worth of Bridget A Ross is at least 675 千$ dollars as of 16 May 2024. Ms. Ross owns over 5,500 units of Lemaitre Vascular Inc stock worth over 674,742$ and over the last 8 years she sold LMAT stock worth over 0$. In addition, she makes 0$ as Independent Director at Lemaitre Vascular Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Ross LMAT stock SEC Form 4 insiders trading

Bridget has made over 5 trades of the Lemaitre Vascular Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently she exercised 5,500 units of LMAT stock worth 165,000$ on 16 May 2024.

The largest trade she's ever made was exercising 7,000 units of Lemaitre Vascular Inc stock on 27 February 2023 worth over 210,000$. On average, Bridget trades about 796 units every 20 days since 2017. As of 16 May 2024 she still owns at least 7,778 units of Lemaitre Vascular Inc stock.

You can see the complete history of Ms. Ross stock trades at the bottom of the page.

Bridget Ross biography

Bridget A. Ross serves as Independent Director of the Company. Since February 2020, Ms. Ross has served as CEO of ChroniSense Medical,Ltd., developer of a wearable medical-grade disease management device, and since January 2020, she has also served as advisor to Picomole, Inc., a medical technology company focused on developing a breath test for lung cancer. Additionally, Ms. Ross serves on the steering committee of MassMedic and as the Executive in Residence for the association's IGNITE accelerator program. From 2017 to 2018, Ms. Ross was President of the Global Medical Group and member of the Executive Management team at Henry Schein, Inc., an international medical and dental product distributor/solutions provider. From 1988 to 2017 she held numerous senior leadership roles at Johnson & Johnson, Inc., including, most recently VP of Commercial Operations for Medical Devices, North America. Ms. Ross holds a Bachelor of Commerce degree from the University of Alberta. The Board has concluded that Ms. Ross should serve on our Board due to her strong executive management skills, knowledge of the medical device industry and breadth of functional, geographic, and therapeutic experience gained during her 30+ year career.

How old is Bridget Ross?

Bridget Ross is 55, she's been the Independent Director of Lemaitre Vascular Inc since 2020. There are 8 older and 19 younger executives at Lemaitre Vascular Inc. The oldest executive at Lemaitre Vascular Inc is Dr. George D. LeMaitre, 87, who is the Founder and Chairman of Scientific Advisory Board.

What's Bridget Ross's mailing address?

Bridget's mailing address filed with the SEC is C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON, MA, 01803.

Insiders trading at Lemaitre Vascular Inc

Over the last 18 years, insiders at Lemaitre Vascular Inc have traded over 169,251,022$ worth of Lemaitre Vascular Inc stock and bought 22,755 units worth 292,783$ . The most active insiders traders include George W Le Maitre、Guido J Neels、David B Roberts. On average, Lemaitre Vascular Inc executives and independent directors trade stock every 10 days with the average trade being worth of 1,488,890$. The most recent stock trade was executed by David B Roberts on 13 August 2024, trading 3,063 units of LMAT stock currently worth 107,236$.

What does Lemaitre Vascular Inc do?

lemaitre vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. the company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. the company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. the company is listed on nasdaq.

Complete history of Ms. Ross stock trades at Henry Schein、Lemaitre Vascular Inc

Lemaitre Vascular Inc executives and stock owners

Lemaitre Vascular Inc executives and other stock owners filed with the SEC include:

• George LeMaitre,
  Chairman of the Board, Chief Executive Officer
• David Roberts,
  President, Director
• Joseph Pellegrino,
  Chief Financial Officer, Director
• George W. LeMaitre,
  Chairman & CEO
• Trent Kamke,
  Senior Vice President - Operations
• David B. Roberts,
  Pres & Director
• Joseph P. Pellegrino Jr.,
  CFO, Treasurer, Sec. & Director
• Trent G. Kamke,
  Sr. VP of Operations
• John O'Connor,
  Independent Director
• Lawrence Jasinski,
  Independent Director
• John Roush,
  Independent Director
• Bridget Ross,
  Independent Director
• James Russell,
  Director, Operations
• Helen Goulding,
  Director, Sales - Northern Europe
• Ryan Connelly,
  Vice President - Research & Development
• Xiang Zhang,
  Vice President, Regulatory Affairs
• Jacob Petersen,
  Vice President, Asia-Pac
• Jonathan Ngau,
  Vice President - Information Technology
• Roli Kumar-Choudhury,
  Vice President, Quality Affairs
• Kimberly Cieslak,
  Vice President - Marketing
• Chance Kriesel,
  Vice President - Sales, The Americas
• Giovannella Deiure,
  Vice President, Sales – Southern Europe
• Stephane Maier,
  Vice President, EMEA Operations
• Andrew Hodgkinson,
  Senior Vice President - Clinical, Regulatory and Quality Affairs
• Laurie Churchill,
  Senior Vice President, General Counsel
• Stephane Maier,
  Sr. VP of EMEA Operations
• Andrew Hodgkinson,
  Sr. VP of Clinical, Regulatory & Quality Affairs
• Daniel J. Mumford,
  Director of HR
• Kimberly L. Cieslak,
  VP of Marketing
• Laurie A. Churchill,
  Sr. VP & Gen. Counsel
• Dr. George D. LeMaitre,
  Founder and Chairman of Scientific Advisory Board
• Cornelia W Le Maitre,
  V.P., Human Resources,Director
• Michael T Wijas,
  VP of Sales, The Americas
• Michael H Thomas,
  Director
• Russell D Hays,
  Director
• Aaron M Grossman,
  General Counsel
• William N Jr Thorndike,
  Director
• Equity Investors Lp/Ma Hous...,
  
• George D Le Maitre,
  Director
• Michael C Jackson,
  Director
• Robert V Linden,
  VP, North American Sales
• Peter R Gebauer,
  President, International OP
• Kevin D Kelly,
  V. P. North American Sales
• Maik D Helmers,
  V.P. Central European Sales
• Guido J Neels,
  Director
• David N Gill,
  Director
• Duane M De Sisto,
  Director
• Martha Shadan,
  Director